Home > Boards > Other Markets > Foreign Stock Markets > Antisoma (LSE:ASM)
Followed By 24
Posts 3088
Boards Moderated 0
Alias Born 01/18/2009

Friday, June 04, 2010 6:53:46 AM

Re: None

Post# of 71
ASCO 2010 - Poster Sessions by Antisoma


AS1411

Saturday June 5, 8:00 AM to 12:00 PM
http://abstract.asco.org/AbstView_74_49933.html
Long-term outcomes of responders in a randomized, controlled phase II trial of aptamer AS1411 in AML.

Monday June 7, 8:00 AM to 12:00 PM
http://abstract.asco.org/AbstView_74_49960.html
A multicenter dose-finding randomized controlled phase IIb study of the aptamer AS1411 in patients with primary refractory or relapsed AML.

Monday June 7, 1:00 PM to 5:00 PM
http://abstract.asco.org/AbstView_74_49790.html
A phase II, single-arm study of AS1411 in metastatic renal cell carcinoma (RCC).


AS1413

Monday June 7, 8:00 AM to 12:00 PM
http://abstract.asco.org/AbstView_74_49982.html
A phase IIa pharmacokinetic and efficacy study of amonafide (AS1413) in combination with cytarabine in patients with acute myeloid leukemia.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y